ScreenerHero

PCLO PharmaCielo Ltd.

TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · pharmacielo.com
0.0600CAD+9.09%Mkt Cap: 9.66M $P/E: —

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetra…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$65.69BUSDP/E 25.5
TAK
Takeda Pharmaceutical Company Limited
$57.82BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.64BUSDP/E 65.2
HLN
Haleon plc
$39.01BUSDP/E 18.1
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.7
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.23BUSDP/E 19.4
VTRS
Viatris Inc.
$20.15BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.27BUSDP/E 111.6
NBIX
Neurocrine Biosciences, Inc.
$14.79BUSDP/E 21.3
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated
$11.23BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.40BUSDP/E 28.4
KRK
Krka, d. d.
$8.63BUSDP/E 19.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.07BUSDP/E 41.4
ALKS
Alkermes plc
$6.99BUSDP/E 109.6
HIMS
Hims & Hers Health, Inc.
$6.88BUSD
LNTH
Lantheus Holdings, Inc.
$6.53BUSDP/E 24.2
KNSA
Kiniksa Pharmaceuticals International, plc
$5.93BUSDP/E 77.9
APTX
Apotex Health Corp.
$5.27BUSD

Key Statistics

Company
Market Cap9.66M USD
Enterprise Value22.06M USD
Revenue (TTM)2.62M USD
Gross Profit528.14K USD
Net Income (TTM)-2.61M USD
Revenue/Share0.02 CAD
Last Price0.0600 CAD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.10
PEG—
EV/EBITDA-15.88
EV/Revenue8.41
P/S3.37
P/B-1.08
EPS (TTM)-0.02
EPS (Forward)-0.05
52W Range
0.035019% of range0.1650
52W High0.1650 CAD
52W Low0.0350 CAD
Profitability
Gross Margin28.59%
Oper. Margin-48.22%
EBITDA Margin-52.93%
Profit Margin-141.06%
ROE32.58%
ROA-28.47%
Growth
Revenue Growth331.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.36M USD
CapEx (TTM)—
FCF Margin-152.35%
FCF Yield-41.40%
Net Debt13.21M USD
Net Debt/EBITDA-9.51
Balance Sheet
Debt/Equity-1.65
Current Ratio0.14
Quick Ratio0.05
Book Value/Sh-0.05 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateJan 18, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.221.01M
Float190.05M
Insiders12.66%
Institutions0.14%
Short Interest
Short Ratio0.4d
Short % Out.0.01%
Shares Short25.05K
Short (prev mo.)25.00K
Technical
SMA 500.0603 (-0.5%)
SMA 2000.0669 (-10.2%)
Beta0.54
S&P 52W Chg14.58%
Avg Vol (30d)64.12K
Avg Vol (10d)57.13K
Technical Indicators
RSI (14)52.3
MACD-0.0021
MACD Signal-0.0026
MACD Hist.+0.0006
BB Upper0.0634 CAD
BB Middle0.0563 CAD
BB Lower0.0491 CAD
BB Width25.47%
ATR (14)0.0058 CAD
Vol Ratio (20d)3.00x